Attached files

file filename
8-K - FORM 8-K - AMERICAN VANGUARD CORPd8k.htm

Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS SECOND QUARTER & MID-YEAR 2011 RESULTS

Quarterly & First Half Performance Reflects Strong Market Demand and Successful Strategy Execution

Newport Beach, CA – August 4, 2011 – American Vanguard Corporation (NYSE:AVD), today announced financial results for the second quarter and six month period ended June 30, 2011.

Fiscal 2011 Second Quarter Financial Highlights – versus Fiscal 2010 Second Quarter:

 

   

Net sales improved from $52.2m to $80.4m, an increase of 54%

 

   

Net income for the period improved from $1.6m to $6.0 million, an increase of 265%

 

   

Earnings per diluted share were $0.22 versus $0.06 in the prior year quarter

Fiscal 2011 First Half Financial Highlights – versus Fiscal 2010 First Half

 

   

Net sales improved from $98.9m to $147.8m, an increased of 49%

 

   

Net income improved from $3.5m to $11.0 million, an increase of 217%

 

   

Earnings per diluted share were $0.40 versus $0.13 in the prior year’s first half

Note: Complete details are available in the financial schedules attached to this press release

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “We are pleased to report performance for the second quarter and the first half of 2011 that reflects the successful execution of our corporate strategy for product portfolio extension, geographic expansion and consistent financial discipline. Strong crop commodity prices have stimulated U.S. agricultural demand in corn, cotton, and a wide variety of other crops, fueling increased purchases of our well-positioned productivity and yield enhancing products. Additionally, we have expanded our international sales penetration driven by the Mocap® and Nemacur® product acquisitions that we completed in December 2010.”

Mr. Wintemute continued: “In keeping with our promise to strengthen and maintain a healthy balance sheet, we have continued to control our inventory levels and carefully maintain our receivable collections performance. In fact, our management of working capital and continuing cash generation provides us with the opportunity to use our positive cash balance for possible debt reduction, dividend payments, product acquisitions or other corporate purposes in the months ahead. Also, during the quarter we were pleased to announce a significant agreement with Monsanto for the co-marketing of our post-emergent corn herbicide Impact® in conjunction with their Roundup® glyphosate brands. The weed management benefits of this combination of two market leading brands will be promoted by both companies and should expand the sales of Impact over the next several years.”


Mr. Wintemute concluded: “We have maintained focus on our gross profit margins by consistently emphasizing profitability in our sales and marketing efforts resulting in an improvement from 37% to 40%. This year our overall manufacturing operations have experienced higher utilization rates resulting in improved coverage of facility fixed costs. We continue to seek the acquisition of appropriately-priced, branded products, similar to our 2010 purchases, as we expand our product offering in key crops. In our product development program, we expect our new potato sprout inhibitor SmartBlock® to become commercial during the first half of 2012. By adding high-value/high-margin products to our portfolio, focusing our sales and marketing priorities, achieving greater manufacturing efficiencies and diligently maintaining financial discipline, we expect to continue profitably expanding our global business.”

Conference Call

Eric Wintemute, Chairman & CEO and David Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 12:00 pm EDT / 9:00 am PDT on Thursday, August 4, 2011. Interested parties may participate in the call by dialing (201) 493-6744 please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes. To learn more about American Vanguard, please reference the Company’s web site at www.amvac-chemical.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in the conference call referenced in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

CONTACT:       -OR-       AVD’S INVESTOR RELATIONS FIRM
American Vanguard Corporation             The Equity Group Inc.
William A. Kuser, Director of Investor Relations             www.theequitygroup.com
(949) 260-1200             Lena Cati
williamk@amvac-chemical.com             Lcati@equityny.com
            (212) 836-9611


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Number in thousands except per share data)

(Unaudited)

 

     For the three months
ended June 30
    For the six months
ended June 30
 
     2011     2010     2011     2010  

Net sales

   $ 80,374      $ 52,172      $ 147,770      $ 98,884   

Cost of sales

     48,381        32,939        87,504        60,727   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     31,993        19,233        60,266        38,157   

Operating expenses

     21,310        15,683        40,396        30,712   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     10,683        3,550        19,870        7,445   

Interest expense

     978        906        1,785        1,806   

Interest capitalized

     (16     (39     (74     (49

Extinguishment of debt

     —          —          546        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income tax

     9,721        2,683        17,613        5,688   

Income tax expense

     3,714        1,040        6,594        2,218   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 6,007      $ 1,643      $ 11,019      $ 3,470   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share—basic

   $ .22      $ .06      $ .40      $ .13   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share—assuming dilution

   $ .22      $ .06      $ .40      $ .13   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—basic

     27,548        27,343        27,538        27,344   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—assuming dilution

     27,838        27,650        27,813        27,633   
  

 

 

   

 

 

   

 

 

   

 

 

 


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Number in thousands, except per share data)

 

     June. 30,
2011
    Dec. 31,
2010
 
     (Unaudited)     (Note)  
ASSETS   

Current assets:

    

Cash

   $ 9,958      $ 1,158   

Receivables:

    

Trade, net of allowance for doubtful accounts of $460 and $447, respectively

     74,953        33,833   

Other

     162        263   
  

 

 

   

 

 

 
     75,115        34,096   
  

 

 

   

 

 

 

Inventories

     80,620        74,054   

Prepaid expenses

     3,289        2,591   

Income taxes receivable

     —          6,715   
  

 

 

   

 

 

 

Total current assets

     168,982        118,614   

Property, plant and equipment, net

     39,170        40,541   

Intangible assets

     119,104        115,249   

Other assets

     4,934        5,775   
  

 

 

   

 

 

 
   $ 332,190      $ 280,179   
  

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY   

Current liabilities:

    

Current installments of long-term debt

   $ 14,827      $ 8,429   

Current installments of other liabilities

     2,073        —     

Accounts payable

     23,996        13,961   

Deferred revenue

     94        5,568   

Accrued program costs

     34,519        16,976   

Accrued expenses and other payables

     5,354        4,634   

Income taxes payable

     167        —     
  

 

 

   

 

 

 

Total current liabilities

     81,030        49,568   

Long-term debt, excluding current installments

     56,213        53,710   

Other liabilities, excluding current installments

     6,787        3   

Deferred income taxes

     10,461        10,461   
  

 

 

   

 

 

 

Total liabilities

     154,491        113,742   
  

 

 

   

 

 

 

Commitments and contingent liabilities

    

Stockholders’ equity:

    

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

     —          —     

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 29,827,874 shares at June 30, 2011 and 29,735,928 shares at December 31, 2010

     2,983        2,974   

Additional paid-in capital

     44,975        43,403   

Accumulated other comprehensive loss

     (960     (448

Retained earnings

     133,854        123,661   
  

 

 

   

 

 

 
     180,852        169,590   

Less treasury stock, at cost, 2,260,996 shares at June 30, 2011 and at December 31, 2010

     (3,153     (3,153
  

 

 

   

 

 

 

Total stockholders’ equity

     177,699        166,437   
  

 

 

   

 

 

 
   $ 332,190      $ 280,179   
  

 

 

   

 

 

 

Note: The balance sheet at December 31, 2010 has been derived from the audited financial statements at that date.


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Numbers in thousands, except share data)

For The Six Months Ended June 30, 2011 and 2010

(Unaudited)

 

Increase (decrease) in cash

   2011     2010  

Cash flows from operating activities:

    

Net income

   $ 11,019      $ 3,470   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization of fixed and intangible assets

     6,733        5,444   

Amortization of other long term assets

     1,934        1,566   

Amortization of discounted liabilities

     988        —     

Stock-based compensation

     1,031        504   

Changes in assets and liabilities associated with operations:

    

Increase in net receivables

     (41,019     (2,540

Increase in inventories

     (6,566     (2,027

Increase in prepaid expenses and other assets

     (1,791     (785

Decrease in income tax receivable/payable, net

     8,133        —     

Increase in accounts payable

     9,089        4,581   

Decrease in deferred revenue

     (5,474     —     

Increase (decrease) in other liabilities

     18,220        (1,786
  

 

 

   

 

 

 

Net cash provided by operating activities

     2,297        8,427   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Capital expenditures

     (2,322     (4,613
  

 

 

   

 

 

 

Net cash used in investing activities

     (2,322     (4,613
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Net (repayments) borrowings under line of credit agreement

     (7,300     600   

Principal payments on long-term debt

     (4,004     (4,053

Borrowings on long-term debt

     20,063        —     

Proceeds from the issuance of common stock (sale of stock under ESPP and exercise of stock option)

     550        277   

Payment of cash dividends

     (826     (271
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     8,483        (3,447
  

 

 

   

 

 

 

Net increase in cash

     8,458        367   

Cash and cash equivalents at beginning of year

     1,158        383   

Effect of exchange rate changes on cash

     342        179   
  

 

 

   

 

 

 

Cash and cash equivalents as of June 30

   $ 9,958      $ 929